MiMedx Group MDXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.86M-171% | $15.19M-9.3% | $16.75M+74.1% | $9.62M+37.0% | $7.02M-5.6% | ||
| -$1.7M-169% | $2.46M-49.9% | $4.92M+3.5% | $4.75M+11.5% | $4.26M-9.2% | ||
| $4.53M+321% | -$2.05M+64.3% | -$5.75M-1,904% | -$287K+53.8% | -$621K+73.3% | ||
| $1.46M-56.5% | $3.37M+63.7% | $2.06M+486% | $351K-52.7% | $742K+63.4% | ||
| -$28.21M-3,280% | $887K-91.9% | $11.01M+51.1% | $7.29M+1.2% | $7.2M+220% | ||
| $889K— | —— | $1.61M+96.6% | $820K+212% | $263K— | ||
| $1.94M— | —— | $2.91M— | —— | $1.46M— | ||
| -$375K— | —— | $284K-92.1% | $3.6M+5,033% | -$73K— | ||
| -$2.01M-165% | $3.12M-9.4% | $3.44M+180% | $1.23M+19.1% | $1.03M— | ||
| $250K-82.9% | $1.47M+1,433% | -$110K+91.0% | -$1.23M-871% | $159K— | ||
| $118K+20.4% | $98K-60.6% | $249K+94.5% | $128K-22.9% | $166K+49.5% | ||
| $330K+1.5% | $325K+2.2% | $318K+1.9% | $312K+1.6% | $307K-9.2% | ||
| $1.88M-92.5% | $24.96M-14.9% | $29.33M+103% | $14.42M+172% | $5.3M-71.8% | ||
| $570K+100% | $285K+48.4% | $192K+7.3% | $179K-52.5% | $377K+43.3% | ||
| $5M— | $0-100% | $3.06M+338% | $700K— | $0-100% | ||
| -$5.64M-1,584% | -$335K+93.6% | -$5.26M-493% | -$887K-118% | -$406K+85.3% | ||
| $1.9M+3,627% | $51K-38.6% | $83K-84.2% | $526K-78.6% | $2.46M+8,093% | ||
| -$2.59M-343% | -$583K+32.0% | -$857K+21.7% | -$1.09M+62.0% | -$2.88M-620% | ||
| -$6.35M-126% | $24.04M+3.5% | $23.21M+86.6% | $12.44M+517% | $2.02M-87.1% | ||
| $4.53M+321% | -$2.05M+64.3% | -$5.75M-1,904% | -$287K+53.8% | -$621K+73.3% | ||
| -$15.71M-560% | $3.42M-46.3% | $6.36M+93.8% | $3.28M+181% | -$4.07M-217% | ||
| -$2.01M-165% | $3.12M-9.4% | $3.44M+180% | $1.23M+19.1% | $1.03M— | ||
| $330K+1.5% | $325K+2.2% | $318K+1.9% | $312K+1.6% | $307K-9.2% | ||
| $1.46M-56.5% | $3.37M+63.7% | $2.06M+486% | $351K-52.7% | $742K+63.4% | ||
| —— | $522.25K0.0% | $522.25K0.0% | $522.25K0.0% | $522.25K+5,397% | ||
| $5M— | $0-100% | $3.06M+338% | $700K— | $0-100% | ||
| $570K+100% | $285K+48.4% | $192K+7.3% | $179K-52.5% | $377K+43.3% | ||
| —— | $0— | $0— | $0— | $0+100% | ||
| $1.62M— | —— | $5.29M+67.0% | $3.17M-1.1% | $3.2M— | ||
| $309K+9.6% | $282K-46.2% | $524K+64.8% | $318K+87.1% | $170K+113% | ||
| $72K— | —— | $2K-75.0% | $8K-72.4% | $29K— | ||
| -$375K-121% | $1.75M+800% | -$250K0.0% | -$250K0.0% | -$250K-114% | ||
| $1.31M-94.7% | $24.67M-15.3% | $29.14M+105% | $14.24M+189% | $4.92M-73.4% | ||
| $1.31M-94.7% | $24.67M-15.3% | $29.14M+105% | $14.24M+189% | $4.92M-73.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MiMedx Group generate?
- MiMedx Group (MDXG) generated $70.6M in operating cash flow over the trailing twelve months.
- What is MiMedx Group's free cash flow?
- After $1.2M of capital expenditures, MiMedx Group's free cash flow was $69.4M over the trailing twelve months, up 7.4% year over year.
- Where does MiMedx Group's cash flow data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
